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Objectives
Osteoporosis and bone fractures are correlated to anti-
retroviral treatment. It is not clear, if some substances
inherit greater risk of bone loss than others.
Methods
We measured pyridinoline, desoxipyridinoline crosslinks
and bone specific alkaline phosphatase in 108 HIV posi-
tive patients. We compared patients with and without
antiretroviral treatment. We then analysed patients with
vs. without tenofovir and patients with PI vs NNRTI use.
Results
Bone specific alk. phosphatase, pyridonoline and desoxi-
piridinoline crosslinks and were significantly higher in
patients with ART compared with patients without ART:
25.17 vs 13.22 pg/L (p < 0.001); 83.64 vs 51.23 nmol/
mmol (p < 0.001) and 16.38 vs 9.68 nmol/mmol
(p<0.001)respectively. In contrast, no difference was
found in patients with vs. without tenofovir 26.25 vs
20.18 pg/l (p =0.08); 80.74 vs 85.83 nmol/mmol (p=0.42)
and 19.36 vs 14.00 nmol/mmol (p=0.13) respectively.
Comparison between patients with proteinase inhibitor
vs non-nucleoside inhibitor yielded no difference either
23.07 vs 26.49pg/l (p=0.33); 94.31 vs 80.65 nmol/mmol
(p=0.34) and 18.18 vs 16.29 nmol/mmol (p= 0.52).
Conclusions
Markers for bone turn over are higher in treated vs
untreated patients. No difference concerning tenofovir
use or proteinase inhibitor vs. non-nucleoside inhibitor
use could be found.
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